טוען...
Boosting-Dose Ritonavir Does Not Alter Peripheral Insulin Sensitivity in Healthy, HIVSeronegative Volunteers
BACKGROUND: Some HIV protease inhibitors (PI), including full dose ritonavir (800 mg) and ritonavir-boosted lopinavir, acutely induce insulin resistance in the absence of HIV infection and changes in body composition. Boosting-dose ritonavir (100 to 200 mg) is the most commonly prescribed PI, yet it...
שמור ב:
| Main Authors: | , , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2010
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3164483/ https://ncbi.nlm.nih.gov/pubmed/20595906 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAI.0b013e3181e6a7d9 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|